| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5813452 | Neuropharmacology | 2016 | 15 Pages |
Abstract
Therefore, we validated AMPK as a promising therapeutic target to treat HD, and identified A769662 as a potential therapeutic compound to facilitate the clearance of mHTT.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Carolin Walter, Laura E. Clemens, Amelie J. Müller, Petra Fallier-Becker, Tassula Proikas-Cezanne, Olaf Riess, Silke Metzger, Huu Phuc Nguyen,